Tactile Systems Technology, Inc. (NASDAQ:TCMD - Get Free Report) CEO Sheri Louise Dodd sold 7,762 shares of Tactile Systems Technology stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $12.36, for a total value of $95,938.32. Following the completion of the transaction, the chief executive officer owned 173,479 shares of the company's stock, valued at approximately $2,144,200.44. This represents a 4.28% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Tactile Systems Technology Trading Up 0.2%
Shares of Tactile Systems Technology stock traded up $0.03 on Friday, hitting $12.41. 273,105 shares of the company traded hands, compared to its average volume of 262,658. The stock's 50 day moving average price is $10.50 and its 200-day moving average price is $12.34. The company has a current ratio of 3.79, a quick ratio of 3.36 and a debt-to-equity ratio of 0.11. Tactile Systems Technology, Inc. has a 52 week low of $8.61 and a 52 week high of $21.10. The company has a market cap of $276.62 million, a PE ratio of 20.02 and a beta of 0.96.
Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.05. Tactile Systems Technology had a net margin of 5.06% and a return on equity of 7.72%. The firm had revenue of $78.91 million during the quarter, compared to the consensus estimate of $73.93 million. Equities research analysts predict that Tactile Systems Technology, Inc. will post 0.7 EPS for the current year.
Analysts Set New Price Targets
Several research analysts recently commented on the company. B. Riley reiterated a "neutral" rating and issued a $13.00 price target (up previously from $12.00) on shares of Tactile Systems Technology in a research report on Tuesday, August 5th. Wall Street Zen upgraded Tactile Systems Technology from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. William Blair upgraded Tactile Systems Technology to a "strong-buy" rating in a research report on Tuesday, August 5th. Finally, Piper Sandler lowered Tactile Systems Technology from an "overweight" rating to a "neutral" rating and dropped their target price for the company from $25.00 to $14.00 in a research report on Tuesday, May 6th. Four analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $13.50.
Read Our Latest Report on TCMD
Institutional Trading of Tactile Systems Technology
Several institutional investors and hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC raised its stake in Tactile Systems Technology by 64,350.0% in the first quarter. GAMMA Investing LLC now owns 2,578 shares of the company's stock worth $34,000 after buying an additional 2,574 shares in the last quarter. Virtus Fund Advisers LLC raised its stake in Tactile Systems Technology by 142.0% in the fourth quarter. Virtus Fund Advisers LLC now owns 4,199 shares of the company's stock worth $72,000 after buying an additional 2,464 shares in the last quarter. Quarry LP bought a new position in Tactile Systems Technology in the fourth quarter worth approximately $81,000. Legal & General Group Plc raised its stake in Tactile Systems Technology by 33.2% in the fourth quarter. Legal & General Group Plc now owns 6,257 shares of the company's stock worth $107,000 after buying an additional 1,558 shares in the last quarter. Finally, Oxford Asset Management LLP bought a new position in Tactile Systems Technology in the second quarter worth approximately $124,000. Institutional investors own 83.43% of the company's stock.
Tactile Systems Technology Company Profile
(
Get Free Report)
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
Before you consider Tactile Systems Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tactile Systems Technology wasn't on the list.
While Tactile Systems Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.